DCTH Delcath Systems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DCTH

Price (delayed)

$5.32

Market cap

$130.67M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.94

Enterprise value

$128.16M

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product, HEPZATO KIT™ (melphalan hydrochloride for injection/hepatic delivery system), is ...

Highlights
Delcath Systems's debt has decreased by 36% YoY
Delcath Systems's EPS has increased by 29% YoY and by 11% from the previous quarter
DCTH's quick ratio has surged by 140% year-on-year but it is down by 32% since the previous quarter
DCTH's gross margin is down by 7% year-on-year but it is up by 2.4% since the previous quarter
Delcath Systems's equity has decreased by 36% from the previous quarter
The net income has contracted by 31% YoY and by 6% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.delcath.com
Peers: ICUI ANGO PODD RVP

Key stats

What are the main financial stats of DCTH
Market
Shares outstanding
24.56M
Market cap
$130.67M
Enterprise value
$128.16M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.43
Price to sales (P/S)
41.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
62.07
Earnings
Revenue
$2.07M
EBIT
-$46.24M
EBITDA
-$45.84M
Free cash flow
-$31.31M
Per share
EPS
-$2.94
Free cash flow per share
-$1.93
Book value per share
$0.72
Revenue per share
$0.13
TBVPS
$2.38
Balance sheet
Total assets
$38.61M
Total liabilities
$22.84M
Debt
$10.19M
Equity
$15.78M
Working capital
$20.71M
Liquidity
Debt to equity
0.65
Current ratio
2.26
Quick ratio
1.99
Net debt/EBITDA
0.05
Margins
EBITDA margin
-2,219.9%
Gross margin
69.2%
Net margin
-2,308.9%
Operating margin
-1,849%
Efficiency
Return on assets
-138.4%
Return on equity
-701.7%
Return on invested capital
-606.1%
Return on capital employed
-208.6%
Return on sales
-2,239.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DCTH stock price

How has the Delcath Systems stock price performed over time
Intraday
1.14%
1 week
9.24%
1 month
15.4%
1 year
-6.5%
YTD
27.88%
QTD
11.53%

Financial performance

How have Delcath Systems's revenue and profit performed over time
Revenue
$2.07M
Gross profit
$1.43M
Operating income
-$38.18M
Net income
-$47.68M
Gross margin
69.2%
Net margin
-2,308.9%
Delcath Systems's net margin has shrunk by 72% YoY and by 11% QoQ
DCTH's operating margin is down by 49% year-on-year and by 15% since the previous quarter
The net income has contracted by 31% YoY and by 6% from the previous quarter
Delcath Systems's gross profit has decreased by 30% YoY and by 2.3% from the previous quarter

Growth

What is Delcath Systems's growth rate over time

Valuation

What is Delcath Systems stock price valuation
P/E
N/A
P/B
7.43
P/S
41.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
62.07
Delcath Systems's EPS has increased by 29% YoY and by 11% from the previous quarter
Delcath Systems's equity has decreased by 36% from the previous quarter
The price to sales (P/S) is 102% more than the 5-year quarterly average of 20.5 and 42% more than the last 4 quarters average of 29.1
The company's revenue fell by 24% YoY and by 4.6% QoQ

Efficiency

How efficient is Delcath Systems business performance
The company's return on invested capital has shrunk by 83% YoY but it rose by 36% QoQ
Delcath Systems's ROS has plunged by 80% YoY and by 13% from the previous quarter
The ROE has soared by 78% since the previous quarter
The ROA has increased by 18% YoY and by 10% QoQ

Dividends

What is DCTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DCTH.

Financial health

How did Delcath Systems financials performed over time
The total assets is 69% greater than the total liabilities
DCTH's quick ratio has surged by 140% year-on-year but it is down by 32% since the previous quarter
The total assets has soared by 116% year-on-year but it has declined by 19% since the previous quarter
Delcath Systems's debt is 35% lower than its equity
DCTH's debt to equity has soared by 124% YoY and by 63% QoQ
Delcath Systems's equity has decreased by 36% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.